Complications following infusion, transfusion and therapeutic injection
Notes: Infection due to pulmonary artery catheter (Swan-Ganz catheter) ; Catheter-related bloodstream infection (CRBSI) NOS ; Central line-associated bloodstream infection (CLABSI) ; Bloodstream infection due to Hickman catheter ; Bloodstream infection due to peripherally inserted central catheter (PICC) ; Bloodstream infection due to portacath (port-a-cath) ; Bloodstream infection due to pulmonary artery catheter ; Bloodstream infection due to triple lumen catheter ; Bloodstream infection due to umbilical venous catheter ; Exit or insertion site infection ; Local infection due to Hickman catheter ; Local infection due to peripherally inserted central catheter (PICC) ; Local infection due to portacath (port-a-cath) ; Local infection due to pulmonary artery catheter ; Local infection due to triple lumen catheter ; Local infection due to umbilical venous catheter ; Port or reservoir infection ; Tunnel infection ; Other central line-associated infection ; Other infection due to Hickman catheter ; Other infection due to peripherally inserted central catheter (PICC) ; Other infection due to portacath (port-a-cath) ; Other infection due to pulmonary artery catheter ; Other infection due to triple lumen catheter ; Other infection due to umbilical venous catheter ; Central line-associated infection NOS ; Unspecified infection due to Hickman catheter ; Unspecified infection due to peripherally inserted central catheter (PICC) ; Unspecified infection due to portacath (port-a-cath) ; Unspecified infection due to pulmonary artery catheter ; Unspecified infection due to triple lumen catheter ; Unspecified infection due to umbilical venous catheter ; ABO incompatibility blood transfusion NOS ; Reaction to ABO incompatibility from transfusion NOS ; ABO incompatibility with hemolytic transfusion reaction less than 24 hours after transfusion ; Acute hemolytic transfusion reaction (AHTR) due to ABO incompatibility ; ABO incompatibility with hemolytic transfusion reaction 24 hours or more after transfusion ; Delayed hemolytic transfusion reaction (DHTR) due to ABO incompatibility ; ABO incompatibility with hemolytic transfusion reaction at unspecified time after transfusion ; Hemolytic transfusion reaction (HTR) due to ABO incompatibility NOS ; Delayed serologic transfusion reaction (DSTR) from ABO incompatibility ; Other ABO incompatible blood transfusion ; Other reaction to ABO incompatible blood transfusion ; Reaction due to incompatibility of Rh antigens (C) (c) (D) (E) (e) ; Reaction due to Rh factor in transfusion NOS ; Rh incompatible blood transfusion NOS ; Acute hemolytic transfusion reaction (AHTR) due to Rh incompatibility ; Rh incompatibility with hemolytic transfusion reaction less than 24 hours after transfusion ; Delayed hemolytic transfusion reaction (DHTR) due to Rh incompatibility ; Rh incompatibility with hemolytic transfusion reaction 24 hours or more after transfusion ; Rh incompatibility with hemolytic transfusion reaction at unspecified time after transfusion ; Hemolytic transfusion reaction (HTR) due to Rh incompatibility NOS ; Delayed serologic transfusion reaction (DSTR) from Rh incompatibility ; Other reaction to Rh incompatible blood transfusion ; Reaction due to incompatibility of minor antigens (Duffy) (Kell) (Kidd) (Lewis) (M) (N) (P) (S) ; Non-ABO antigen incompatibility reaction from transfusion NOS ; Acute hemolytic transfusion reaction (AHTR) due to non-ABO incompatibility ; Non-ABO incompatibility with hemolytic transfusion reaction less than 24 hours after transfusion ; Delayed hemolytic transfusion reaction (DHTR) due to non-ABO incompatibility ; Non-ABO incompatibility with hemolytic transfusion reaction 24 or more hours after transfusion ; Hemolytic transfusion reaction (HTR) due to non-ABO incompatibility NOS ; Non-ABO incompatibility with hemolytic transfusion reaction at unspecified time after transfusion ; Delayed serologic transfusion reaction (DSTR) from non-ABO incompatibility ; Other reaction to non-ABO incompatible blood transfusion ; Allergic shock due to serum ; Anaphylactic shock due to serum ; Anaphylactoid reaction due to serum ; Anaphylaxis due to serum ; Intoxication by serum ; Protein sickness ; Serum rash ; Serum sickness ; Serum urticaria ; Infiltration of vesicant agent ; Infiltration of vesicant antineoplastic chemotherapy ; Infiltration of other vesicant agent ; Complication of chimeric antigen receptor (CAR-T) cell therapy ; Complication of IEC therapy ; Delayed serologic transfusion reaction (DSTR), unspecified incompatibility ; Hemolytic transfusion reaction NOS ; Transfusion reaction NOS ; code to identify the vascular complication ; code to identify the specific infection, such as: ; sepsis (A41.9) ; code (R65.2-) to identify severe sepsis, if applicable ; code to identify the specific complication, such as: ; cytokine release syndrome (D89.83-) ; immune effector cell-associated neurotoxicity syndrome (G92.0-) ; code to identify graft-versus-host reaction, if applicable, (D89.81-) ; minor blood group antigens reactions (Duffy) (E) (K) (Kell) (Kidd) (Lewis) (M) (N) (P) (S) (T80.A-) ; ABO incompatibility reaction due to transfusion of blood or blood products (T80.3-) ; allergic reaction or shock NOS (T78.2) ; anaphylactic reaction or shock NOS (T78.2) ; anaphylactic reaction or shock due to adverse effect of correct medicinal substance properly administered (T88.6) ; other serum reaction (T80.6-) ; ABO incompatibility with hemolytic transfusion reaction (T80.31-) ; Non-ABO incompatibility with hemolytic transfusion reaction (T80.A1-) ; Rh incompatibility with hemolytic transfusion reaction (T80.41-) ; bone marrow transplant rejection (T86.01) ; febrile nonhemolytic transfusion reaction (R50.84) ; fluid overload due to transfusion (E87.71) ; posttransfusion purpura (D69.51) ; transfusion associated circulatory overload (TACO) (E87.71) ; transfusion (red blood cell) associated hemochromatosis (E83.111) ; transfusion related acute lung injury (TRALI) (J95.84) ; extravasation of vesicant agent (T80.81-) ; infiltration of vesicant agent (T80.81-) ; vascular complications specified as due to prosthetic devices, implants and grafts (T82.8-, T83.8-, T84.8-, T85.8-) ; postprocedural vascular complications (T81.7-) ; infections specified as due to prosthetic devices, implants and grafts (T82.6-T82.7, T83.5-T83.6, T84.5-T84.7, T85.7) ; postprocedural infections (T81.4-) ; serum hepatitis (B16-B19) ; complication of bone marrow transplant (T86.0) ; complication of stem cell transplant (T86.5)